Zur Kurzanzeige

dc.contributor.authorGarcía Hernández, Violeta 
dc.contributor.authorSánchez Bernal, María Carmen 
dc.contributor.authorSchvartz, Domitille
dc.contributor.authorCalvo Andrés, José Julián 
dc.contributor.authorSanchez, Jean-Charles
dc.contributor.authorSánchez Yagüe, Jesús 
dc.date.accessioned2024-02-01T10:34:20Z
dc.date.available2024-02-01T10:34:20Z
dc.date.issued2018-06-15
dc.identifier.citationGarcía-Hernández, V., Sánchez-Bernal, C., Schvartz, D., Calvo, J. J., Sanchez, J. C., & Sánchez-Yagüe, J. (2018). A tandem mass tag (TMT) proteomic analysis during the early phase of experimental pancreatitis reveals new insights in the disease pathogenesis. Journal of proteomics, 181, 190-200. https://doi.org/10.1016/j.jprot.2018.04.018es_ES
dc.identifier.issn1874-3919
dc.identifier.urihttp://hdl.handle.net/10366/155147
dc.description.abstract[EN]Changes in the protein expression occurring within the initiation phase of acute pancreatitis (AP) might be vital in the development of this complex disease. However, the exact mechanisms involved in the onset of AP remains elusive and most of our knowledge about the pathobiology of AP comes from animal models. We performed in a rat pancreatitic model a high-throughput shotgun proteomic profiling of the soluble and whole membrane fractions from the pancreas during the early phase of cerulein (Cer)-induced AP. We identified 997 proteins, of which 353 were significantly different (22, 276 or 55 in both, the soluble or the membrane fractions, respectively). Gene Ontology and KEGG PATHWAY analyses revealed that these proteins were implicated in molecular mechanisms relevant to AP pathogenesis, including vesicle-mediated and protein transport, lysosomal and mitochondrial impairment or proteolysis. Numerous metabolic processes were downregulated apparently to reduce energy consumption, and a remarkable increase in inflammatory and stress responses was also highlighted. The proteomic data were verified by immunoblotting of 11 and 7 different soluble or membrane-associated proteins, either novel (VPS29 and MCTS1) or known factors in AP. Also, our first observation of the imbalance of some COP proteins during AP early phase deserves further characterization. AP is one of the most important pathological inflammatory states of the exocrine pancreas but its pathophysiology remains incompletely understood, especially the early acinar events. Proteomic analysis of pancreatic subcellular fractions simplifies protein maps and helps in the identification of new protein alterations and biomarkers characterizing pancreatic tissue damage. Our shotgun approach has not been previously used to profile the early proteomic alterations of the disease, which are considered crucial for its development and for the founding of clinical procedures. Furthermore, our subcellular fractionation protocol allowed us to detect changes in membrane proteins so far overlooked in the proteomic study of AP. Accordingly, using TMT proteomics and bioinformatic tools, we were able to detect significant changes in protein expression related to many pathobiological pathways of acute pancreatitis as from the early phase of the disease. To our knowledge, some of these changes, such as the imbalance of some COP proteins, have never been described in this disease.es_ES
dc.language.isoenges_ES
dc.subjectAcute pancreatitises_ES
dc.subjectCeruleines_ES
dc.subjectProteomicses_ES
dc.subjectTandem mass tags (TMT)es_ES
dc.subjectShotgun proteomicses_ES
dc.subject.meshProteomics *
dc.subject.meshMitochondria *
dc.subject.meshAcute Disease *
dc.subject.meshRats *
dc.subject.meshCeruletide *
dc.subject.meshAnimals *
dc.subject.meshPancreatitis *
dc.subject.meshMitochondrial Proteins *
dc.subject.meshProteome *
dc.subject.meshLysosomes *
dc.titleA tandem mass tag (TMT) proteomic analysis during the early phase of experimental pancreatitis reveals new insights in the disease pathogenesises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1016/j.jprot.2018.04.018es_ES
dc.identifier.doi10.1016/j.jprot.2018.04.018
dc.relation.projectIDThis work was supported by Instituto de Salud Carlos III grant PI15/ 01156 (Co-funded by European Regional Development Fund) “Investing in your future”. V. García-Hernández was a recipient of a Spanish predoctoral fellowship from the Ministerio de Educación, Cultura y Deporte (FPU2010-2350) and an EMBO Short-Term fellowship (ASTF523-2014).es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.pmid29678717
dc.identifier.essn1876-7737
dc.journal.titleJournal of Proteomicses_ES
dc.volume.number181es_ES
dc.page.initial190es_ES
dc.page.final200es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsenfermedad aguda *
dc.subject.decsmitocondrias *
dc.subject.decsproteoma *
dc.subject.decsanimales *
dc.subject.decsproteínas mitocondriales *
dc.subject.decsproteómica *
dc.subject.decspancreatitis *
dc.subject.decsratas *
dc.subject.decsceruletida *
dc.subject.decslisosomas *


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige